Braga Pier Carlo, Dal Sasso Monica, Fonti Elena, Culici Maria
Department of Pharmacology, School of Medicine, University of Milan, Milan, Italy.
Pharmacology. 2009;83(2):110-5. doi: 10.1159/000186049. Epub 2008 Dec 18.
Human polymorphonuclear neutrophils (PMN), reactive oxygen species (ROS) and inflammatory reactions are closely interrelated, and increasing attention is being given to the search for new synthetic or natural antioxidant agents, capable of reducing ROS and consequent inflammation. It has been claimed that bisabolol (a monocyclic sesquiterpene alcohol) has an antioxidant/anti-inflammatory activity, but this has almost exclusively been investigated using chemical or biochemical tests. We studied the ability of bisabolol to interfere with ROS production (luminol-amplified chemiluminescence, LACL) during human PMN respiratory bursts induced by both corpusculate(Candida albicans)and soluble stimulants (N-formyl-methionyl-leucyl-phenylalanine, fMLP). LACL was also used to test cell-free systems (SIN-1 and H2O2/HOCl(-) systems) in order to investigate the presence of scavenging activity. After C. albicans stimulation, significant concentration-dependent LACL inhibition was observed at bisabolol concentrations ranging from 7.7 to 31 microg/ml; after the fMLP stimulus, significant LACL inhibition was observed at bisabolol concentrations ranging from 3.8 to 31 microg/ml. A similar effect was observed in the SIN-1 and H2O2/HOCl(-) systems. These findings draw the attention to the possible medical use of bisabolol as a means of improving the antioxidant network and restoring the redox balance by antagonising oxidative stress.
人类多形核中性粒细胞(PMN)、活性氧(ROS)和炎症反应密切相关,人们越来越关注寻找能够减少ROS及随之而来的炎症的新型合成或天然抗氧化剂。据称,红没药醇(一种单环倍半萜醇)具有抗氧化/抗炎活性,但几乎完全是通过化学或生化试验进行研究的。我们研究了红没药醇在由微粒体(白色念珠菌)和可溶性刺激物(N-甲酰甲硫氨酰亮氨酰苯丙氨酸,fMLP)诱导的人类PMN呼吸爆发过程中干扰ROS产生(鲁米诺增强化学发光,LACL)的能力。LACL还用于测试无细胞系统(SIN-1和H2O2/HOCl(-)系统),以研究清除活性的存在。在白色念珠菌刺激后,在浓度范围为7.7至31微克/毫升的红没药醇中观察到显著的浓度依赖性LACL抑制;在fMLP刺激后,在浓度范围为3.8至31微克/毫升的红没药醇中观察到显著的LACL抑制。在SIN-1和H2O2/HOCl(-)系统中也观察到了类似的效果。这些发现引起了人们对红没药醇可能的医学用途的关注,即通过对抗氧化应激来改善抗氧化网络并恢复氧化还原平衡。